Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy

by Lachlan Angus, Shalem Leemaqz, Olivia Ooi, Pauline Cundill, Nicholas Silberstein, Peter Locke, Jeffrey D Zajac, Ada S Cheung
Published 2019-07-01

Trial and error: evaluating and refining a community model of HIV testing in Australia

by Kathleen E. Ryan, Alisa Pedrana, David Leitinger, Anna L. Wilkinson, Peter Locke, Margaret E. Hellard, Mark Stoové
Published 2017-10-01

Relationships between body mass index with oral estradiol dose and serum estradiol concentration in transgender adults undergoing feminising hormone therapy

by Brendan J. Nolan, Adam Brownhill, Ingrid Bretherton, Peggy Wong, Susan Fox, Peter Locke, Nicholas Russell, Mathis Grossmann, Jeffrey D. Zajac, Ada S. Cheung
Published 2020-05-01

Feminizing Hormone Therapy Prescription Patterns and Cardiovascular Risk Factors in Aging Transgender Individuals in Australia

by Matthew I. Balcerek, Brendan J. Nolan, Brendan J. Nolan, Adam Brownhill, Peggy Wong, Peter Locke, Jeffrey D. Zajac, Jeffrey D. Zajac, Ada S. Cheung, Ada S. Cheung
Published 2021-07-01

A comparative, retrospective analysis of HIV testing among gay, bisexual and other men who have sex with men in Melbourne, Australia

by Kathleen E. Ryan, Anna L. Wilkinson, Eric Chow, Tim Read, Marcus Chen, Peter Locke, David Leitinger, Catriona Bradshaw, Alisa Pedrana, Margaret Hellard, Christopher K. Fairley, Mark Stoové
Published 2019-10-01